Trial intelligence / Profile preview

Propofol vs Sevoflurane in Elderly Cancer Surgery

NCT05343260Completed

Sponsor
Peking University First Hospital
Start
Apr 2015
Primary completion
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of propofol injection (veterinary) in solid organ cancer (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Overall Survival at 5 years. Started Apr 2015; status: completed.

02

Drugs

propofol injection (veterinary)
03

Conditions

solid organ cancer

Beyond the preview

Go deeper on NCT05343260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05343260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call